People were dying, hospitals were overflowing, but even by January 2021 we already knew ivermectin could save three quarters of those who died. Randomized trials of 2,282 people showed that only 2% of people on ivermectin died, compared to nearly 10% of the hapless people who missed out, yet he picked the "missed out" path.

Everything pointed in the right direction. The result of the meta-study was highly significant (p=0.0002!), the risks were almost nothing, the outcome was extraordinary, the effect was dependent on the dose, and the blood markers of inflammation were also reduced, as we'd expect.